Evidence-Based

Administered by trained healthcare personnel to thousands of patients for more than a decade and supported by a vast array of clinical evidence, the UltraMIST® System’s acoustic wave therapy promotes healing by controlling inflammation and reducing bacteria in the wound bed while increasing angiogenesis. Further, promoting healing increases perfusion through vasodilation, ultimately increasing oxygen and nutrients in the tissue.

The UltraMIST®  System mechanically removes barriers and promotes healing in various wound types. Indications include, but are not limited to, diabetic foot ulcers, venous leg ulcers, pressure ulcers, and surgical, burn, and deep tissue injuries. It also reduces and removes many bacteria, including biofilms, while preserving healthy structures. 

By activating the body’s normal regeneration process, the UltraMIST® System offers significant wound healing advantages. First, it reduces barriers to healing by reducing bacterial overgrowth, disrupting bacterial biofilms, and controlling inflammation. At the same time, UltraMIST® System therapy promotes healing through vasodilation and by accelerating angiogenesis. A meta-analysis of clinical evidence in cases including diabetic foot, ischemic, neuropathic, venous, multifactorial, pressure, surgical, and traumatic ulcers shows that wound closure increased from 24% with standard care to 42% with UltraMIST® use over a 12-week interval.

To accelerate wound healing even more, in between the UltraMIST® System treatments, other standard or advanced wound therapies may be incorporated into the treatment plan — at the discretion of the wound care professional. The result? Faster relief and better quality of life for your patients with less time and resources on costly treatments that don’t work. These savings make the UltraMIST® System a financially viable solution for the patient, the provider, and the healthcare system.

UltraMIST® achieved an 85% Area Reduction in 7 weeks across a wide range of chronic and acute wounds